Have an issue with your financial adviser or looking for a new one? Email questions or concerns to [email protected].

Investors are left with a market where they should keep looking for “babies that get thrown out with the bathwater,” when ...

Please don’t tell me to ‘eat at home if you can’t afford to tip’ because it’s not about whether I can afford it or not.” ...

Apple is seen as behind the pack in AI, and the company will have a chance to change that perception with its WWDC keynote on ...

“The one thing I tell all of my clients heading towards retirement is ‘find things to do.’ For a majority, it is a mind ...

Spectris shares jumped after the company said it received a 3.93 billion pound ($5.32 billion) takeover proposal from Advent International that it would be prepared to recommend to shareholders if a ...

Merck, which is evaluating the safety and efficacy of enlicitide for the treatment of adults with hyperlipidemia on lipid-lowering therapies, including at least a statin, said the Phase 3 studies met ...

At Apple's last WWDC a year ago, the company showed off some new AI features that have still yet to materialize. This time around, the company might take a more subdued approach. "We think Apple will ...

Shares of NewAmsterdam Pharma rose in premarket trading Monday after finding positive benefits for treating Alzheimer's Disease in its cholesterol drug study. Shares traded 9.2% higher ahead of the ...

Talon Metals is looking to raise up to 24 million Canadian dollars ($17.5 million) through private placements to develop its nickel project in Minnesota.

Axsome Therapeutics received a refusal-to-file letter from the Food and Drug Administration for its new drug application for its fibromyalgia drug AXS-14.

Argentex Group shares rose after the company said it had received a proposal from Lavide Holding to invest 2.5 million pounds ($3.4 million) for a 50% shareholding in the company, which it rejected.